Blog - Page 16 of 5516 - QualityStocks

ThursdayDec 04, 2025 9:05 am

QualityStocksNewsBreaks – Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Closes $1.7 Million Private Placement

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising. Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) announced it has closed its non-brokered private placement, raising $1,699,185 through the issuance of 1,179,990 common shares at $1.44 per share. The Company paid $135,934 in finders fees in accordance with applicable securities laws and Canadian Securities Exchange policies. The shares are subject to a four month hold period under Canadian securities laws. Proceeds will support research and development, potential synergetic acquisitions, and working capital. To view the full press release, visit https://ibn.fm/VNKaz About ShelfieTech ShelfieTech is a technology…

ThursdayDec 04, 2025 9:00 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) Plans $1.12M Non-Brokered Private Placement

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) announces plans to raise up to $1.12 million through a non-brokered private placement of up to 2,000,000 flow-through units priced at $0.56 each. Each unit includes one flow-through common share and one-half warrant, with whole warrants exercisable at $0.65 for 36 months. Proceeds will be used for qualifying Canadian exploration expenses under the Income Tax Act. The placement is subject to customary closing conditions, includes a four month and one day hold period, and may involve 6% cash…

ThursdayDec 04, 2025 9:00 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Forms Massimo AI Technology to Expand into Robotics Markets

Massimo Group (NASDAQ: MAMO) has established Massimo AI Technology Inc., a wholly owned subsidiary created to advance the company into industrial and service robotics while supporting its long-term technology roadmap. The new division will develop practical automation and warehouse-assistance platforms, build a dedicated robotics supply and manufacturing foundation, and leverage Massimo’s existing strengths in electric systems and global operations. Leadership says the initiative broadens the company’s technology base, opens potential entry into high-growth automation sectors, and supports diversified long-term revenue opportunities. To view the full press release, visit https://ibn.fm/2P71E About Massimo Group (NASDAQ: MAMO) Massimo Group is a manufacturer and distributor…

ThursdayDec 04, 2025 9:00 am

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Is ‘One to Watch’

Disseminated on behalf of ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) and may include paid advertising. ShelfieTech delivers an AI- and robotics-driven retail inventory platform designed to address long-standing accuracy and efficiency challenges in large-store environments. The company’s proprietary machine-learning and computer-vision technology provides real-time insights that help retailers maintain consistent stock levels and reduce revenue losses from out-of-stock scenarios. Additional tools, including a mobile employee app, cloud-based management dashboard and built-in advertising capabilities, create a complete operational ecosystem. Market statistics highlighting low human accuracy and high error rates in manual inventory validate the need for automated, data-reliable retail solutions. ShelfieTech…

WednesdayDec 03, 2025 3:34 pm

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance

Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is aligned with a major federal shift as the War Department moves to acquire roughly 300,000 low-cost drones under President Trump’s “Unleashing American Drone Dominance” initiative. The department’s new request for information outlines a $1 billion procurement program beginning in early 2026 that will fund four production “gauntlets,” starting with 12 vendors delivering 30,000 drones at $5,000 per unit and scaling toward 150,000 units at reduced costs. Secretary of War Pete Hegseth said the program aims to rebuild U.S. industrial capacity, integrate unmanned systems into all…

WednesdayDec 03, 2025 3:30 pm

QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO

Gloo (NASDAQ: GLOO) , a technology platform serving the faith and flourishing ecosystem, priced its initial public offering of 9,100,000 shares of Class A common stock at $8 per share and granted underwriters a 30-day option to purchase up to 1,365,000 additional shares. Trading is expected to begin on the Nasdaq Global Select Market under the symbol GLOO, with the offering slated to close Nov. 20, 2025, subject to customary conditions. Roth Capital Partners is serving as sole book-running manager, with The Benchmark Company, Craig-Hallum Capital Group, Lake Street Capital Markets, Loop Capital Markets, and Texas Capital Securities acting as…

WednesdayDec 03, 2025 2:33 pm

QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants

Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8 million registered offering consisting of 13,333,333 Class A ordinary shares at $0.60 per share and warrants to purchase 26,666,666 additional shares at 110 percent of the offering price with a 120-day term. Gross proceeds totaled $8 million before expenses, and the company plans to use the net proceeds to support business expansion, R&D, river-water quality management initiatives, wastewater treatment technology upgrades, and talent recruitment. The offering was conducted on a reasonable best-effort basis, with D. Boral Capital LLC serving as placement agent. To view the…

WednesdayDec 03, 2025 12:26 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold

Oncotelic Therapeutics (OTCQB: OTLC), 45% owner of the Sapu Nano joint venture, announced new pharmacokinetic and tissue-distribution data showing that Sapu003, its intravenous Deciparticle (TM) formulation of everolimus, dramatically reduces gastrointestinal drug accumulation compared with oral everolimus. Oral dosing drives extreme gut exposure—up to 2,448× plasma levels in the stomach—while IV Sapu003 limits GI tissue levels to just 36–48× plasma, representing reductions of up to 67-fold. The company stated that this shift may improve tolerability, maintain the drug’s intrinsic metabolic profile, and provide more consistent systemic exposure. To view the full press release, visit https://ibn.fm/TWsDZ About Oncotelic Therapeutics Inc. Oncotelic Therapeutics…

WednesdayDec 03, 2025 12:00 pm

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Leading Charge in Retail’s Smart-Cart Revolution

A2Z Cust2Mate Solutions specializes in creating, commercializing smart-cart solutions for grocery stores, supermarkets and other retail formats. The company’s mission is to “unlock the full potential of every in-store shopping journey, through digitalization and personalization.” Cust2Mate supports a digital in-store experience that closely bridges online and brick-and-mortar shopping. From checkout lanes to connected carts, the retail experience is being reinvented — and A2Z Cust2Mate Solutions (NASDAQ: AZ) is at the forefront of the movement. A2Z develops and deploys “smart-cart” technology that aims to transform how consumers shop in physical stores by melding convenience, personalization and data intelligence into the traditional…

WednesdayDec 03, 2025 11:45 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Details Encouraging LP-184 Phase 1a Results Showing Durable Disease Control in Advanced Solid Tumors

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company using artificial intelligence and genomics to transform oncology drug development, reported additional details and clinical insights from its completed Phase 1a dose-escalation study of LP-184 along with highlights from a recent webinar. The study in 63 heavily pre-treated patients with advanced solid tumors met all primary endpoints for safety and tolerability and established a clear recommended Phase 2 dose. Encouraging signals of durable disease control were observed, particularly in tumors with DNA damage repair pathway deficiencies. Building on these results, Lantern is advancing multiple biomarker-guided Phase 1b/2 trials across triple-negative breast cancer,…

Site Search

Company Search

QualityStocksNewsBreaks – Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Closes $1.7 Million Private Placement

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) Plans $1.12M Non-Brokered Private Placement

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Forms Massimo AI Technology to Expand into Robotics Markets

ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Is ‘One to Watch’

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance

QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO

QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Leading Charge in Retail’s Smart-Cart Revolution

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Details Encouraging LP-184 Phase 1a Results Showing Durable Disease Control in Advanced Solid Tumors

Market Basics

Newsletter Publishers

Public Companies